Full Text View
Tabular View
No Study Results Posted
Related Studies
Korean Post-marketing Surveillance for Sprycel®
This study is currently recruiting participants.
Verified March 2012 by Bristol-Myers Squibb
Study NCT01464047   Information provided by Bristol-Myers Squibb

First Received on October 10, 2011.   Last Updated on March 5, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Leukemia, Myelomonocytic, Chronic
Leukemia-Lymphoma
Additional conditions recognized in this trial
Leukemia
Lymphoma
More general conditions related to this trial
Bone Marrow Diseases
Hematologic Diseases
Immune System Diseases
Immunoproliferative Disorders
Leukemia, Myeloid
Lymphatic Diseases
Lymphoproliferative Disorders
Myelodysplastic-Myeloproliferative Diseases
Neoplasms
Neoplasms by Histologic Type
Additional drug interventions recognized in this trial
Dasatinib
More general drug interventions related to this trial
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Protein Kinase Inhibitors
Sponsors listed in this trial
Bristol-Myers Squibb


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services